|
[1] SIEGEL RL,MILLER KD,JEMAL A. Cancer statistics,2019[J]. CA Cancer J Clin,2019,69(1):7-34.
|
|
[2] ZHENG RS,SUN KX,ZHANG SW,et al. Report of cancer epidemiology in China,2015[J]. Chin J Oncol,2019,41(1):19-28.(in Chinese)郑荣寿，孙可欣，张思维，等．2015年中国恶性肿瘤流行情况分析[J]．中华肿瘤杂志，2019,41(1):19-28.
|
|
[3] PAGET S. The distribution of secondary growths in cancer of the breast[J]. Lancet,1889,133:571-573.
|
|
[4] DOUGAN SK. The pancreatic cancer microenvironment[J].Cancer J,2017,23(6):321-325.
|
|
[5] WU CZ,HAN X,WANG Y. Tumor microenvironment and its regulation of immunity,vessels,metabolism,and nutrition[J/CD]. Electronic J Metab Nutr Cancer,2016,3(4):220-223.(in Chinese)吴朝真，韩晓，王悦．肿瘤微环境及其调节的免疫、血管及代谢营养[J/CD]．肿瘤代谢与营养电子杂志，2016,3(4):220-223.
|
|
[6] REN B,CUI M,YANG G,et al. Tumor microenvironment participates in metastasis of pancreatic cancer[J]. Mol Cancer,2018,17(1):108.
|
|
[7] ZHAI ZS,ZHANG HW. Hypoxic microenvironment in inhibiting tumor metastasis[J]. J Chin Pract Diagn Ther,2019,33(2):191-193.(in Chinese)翟振胜，张宏伟．缺氧微环境调控肿瘤转移研究进展[J]．中华实用诊断与治疗杂志，2019,33(2):191-193.
|
|
[8] MANOOCHEHRI KHOSHINANI H,AFSHAR S,NAJAFI R. Hypoxia:A double-edged sword in cancer therapy[J]. Cancer Invest,2016,34(10):536-545.
|
|
[9] ERKAN M,KURTOGLU M,KLEEFF J. The role of hypoxia in pancreatic cancer:A potential therapeutic target?[J]. Expert Rev Gastroenterol Hepatol,2016,10(3):301-316.
|
|
[10] YE L,TANG ZG. Research progress of hypoxia inducible factor in pancreatic cancer[J]. Med Recapitulate,2019,25(10):1949-1953.(in Chinese)叶林，汤志刚．缺氧诱导因子在胰腺癌中的研究进展[J]．医学综述，2019,25(10):1949-1953.
|
|
[11] HUANG RQ. Influence on hypoxia induced factor-1 for invasive metastasis of tumor[J]. Lingnan Mod Clin Surg,2011,11(3):232-235.(in Chinese)黄锐钦．缺氧诱导因子-1α对肿瘤侵袭转移的影响[J]．岭南现代临床外科，2011,11(3):232-235.
|
|
[12] WANG M,CHEN MY,GUO XJ,et al. Expression and significance of HIF-1αand HIF-2αin pancreatic cancer[J]. J Huazhong Univ Sci Technolog Med Sci,2015,35(6):874-879.
|
|
[13] ZHOU X,GUO X,CHEN M,et al. HIF-3αpromotes metastatic phenotypes in pancreatic cancer by transcriptional regulation of the Rho C-ROCK1 signaling pathway[J]. Mol Cancer Res,2018,16(1):124-134.
|
|
[14] MAO M,LI Q,QIU YL,et al. Production of reactive oxygen species in the mitochondria and its mechanism of action in regulating hypoxic pulmonary hypertension[J]. J Harbin Med Univ,2014,48(6):525-527,531.(in Chinese)毛敏，李倩，邱艳丽，等．线粒体活性氧的产生及调节缺氧性肺动脉高压作用机制[J]．哈尔滨医科大学学报，2014,48(6):525-527,531.
|
|
[15] HOSEIN AN,BEG MS. Pancreatic cancer metabolism:Molecular mechanisms and clinical applications[J]. Curr Oncol Rep,2018,20(7):56.
|
|
[16] SUNAMI Y,REBELO A,KLEEFF J,et al. Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells[J].Cancers(Basel),2017,10(1):e3.
|
|
[17] ICARD P,SHULMAN S,FARHAT D,et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?[J]. Drug Resist Updat,2018,38:1-11.
|
|
[18] YANG YH,ZHANG YX,GUI Y,et al. Research advances in the role of autophagy and perineural invasion in pancreatic cancer[J]. J Clin Hepatol,2018,34(11):2475-2479.(in Chinese)杨延辉，张玉祥，桂洋，等．胰腺癌与自噬、神经浸润的关系[J]．临床肝胆病杂志，2018,34(11):2475-2479.
|
|
[19] DANIEL SK,SULLIVAN KM,LABADIE KP,et al. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma[J].Clin Transl Med,2019,8(1):10.
|
|
[20] ZHANG GF,CAI JQ,CUI TJ,et al. Effects of CD40 pathway on the biological behavior of pancreatic cancer cells[J]. Chin J Clin Pharmacol Ther,2018,23(7):755-760.(in Chinese)张桂枫，蔡加琴，崔同建，等．CD40调节胰腺癌细胞生物学行为的研究[J]．中国临床药理学与治疗学，2018,23(7):755-760.
|
|
[21] JEIN YK,PARK SG,CHOI IW,et al. Cancer cell-associated cytoplasmic B7-H4 is induced by hypoxia through hypoxiainducible factor-1αand promotes cancer cell proliferation[J]. Biochem Biophys Res Commun,2015,459(2):277-283.
|
|
[22] BARBU A,LEJONKLOU MH,SKOGSEID B. Progranulin stimulates proliferation of mouse pancreatic islet cells and is overexpressed in the endocrine pancreatic tissue of an MEN1mouse model[J]. Pancreas,2016,45(4):533-540.
|
|
[23] LI Y,ZHANG X,YANG J,et al. Methylation of BNIP3 in pancreatic cancer inhibits the induction of mitochondrial-mediated tumor cell apoptosis[J]. Oncotarget,2017,8(38):63208-63222.
|
|
[24] HARASHIMA N,TAKENAGA K,AKIMOTO M,et al. HIF-2αdictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression[J]. Oncotarget,2017,8(26):42887-42900.
|
|
[25] WANG P,WAN WW,XIONG SL,et al. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma,hepatoma and lung cancer[J]. Cell Death Discov,2017,3:16105.
|
|
[26] ZHENG G,LIU JS,ZHI RH. Expression and clinical significance of CTGF,VEGF and HIF-1αin pancreatic carcinoma[J]. China Med Herald,2011,8(13):31-33.(in Chinese)郑刚，刘建生，智仁厚．结缔组织生长因子、血管内皮生长因子、缺氧诱导因子-1α在胰腺癌中的表达及临床意义[J]．中国医药导报，2011,8(13):31-33.
|
|
[27] YANG J,ZHU DM,ZHOU XG,et al. HIF-2αpromotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter[J]. Oncotarget,2017,8(29):47801-47815.
|
|
[28] WANG SG,SHAN YZ,ZHOU LM,et al. Effect of HIF-1αon the epithelial mesenchymal transition and invasion and migration of pancreatic cancer cells under hypoxic condition[J].Mod Oncol,2016,24(11):1704-1709.(in Chinese)王时光，单远洲，周联明，等．缺氧微环境下HIF-1α对胰腺癌细胞上皮间质转化及侵袭迁移的影响[J]．现代肿瘤医学，2016,24(11):1704-1709.
|
|
[29] WU Y,LIU DF,ZHANG C,et al. Hypoxic stellate cells of pancreatic cancer stroma induce cancer cell migration and invasion via CCL7/CCR5 axis[J]. Acta Univ Med Nanjing,2017,37(5):521-525,543.(in Chinese)吴飏，刘东方，张纯，等．缺氧微环境中胰腺星状细胞通过CCL7/CCR5轴促进胰腺癌侵袭[J]．南京医科大学学报，2017,37(5):521-525,543.
|
|
[30] ZHANG Q,LOU Y,ZHANG J,et al. Hypoxia-inducible factor-2αpromotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer[J]. Mol Cancer,2017,16(1):119.
|
|
[31] LIU WZ,HU Y,ZHANG C. Research progress in tumor microenvironment and immunotherapy of pancreatic cancer[J].Chin J Immunol,2018,34(12):1901-1906.(in Chinese)刘文增，胡渊，张彩．胰腺癌的肿瘤微环境及其免疫治疗研究进展[J]．中国免疫学杂志，2018,34(12):1901-1906.
|
|
[32] GRASSO C,JANCEN G,GIOVANNRTTI E. Drug resistance in pancreatic cancer:Impact of altered energy metabolism[J].Crit Rev Oncol Hematol,2017,114:139-152.
|
|
[33] GAIANIGO N,MELISI D,CARBONE C. EMT and treatment resistance in pancreatic cancer[J]. Cancers(Basel),2017,9(9):e122.
|
|
[34] HE X,WANG J,WEI W,et al. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1αand contributes to chemoresistance in pancreatic cancer cells[J]. Cancer Biol Ther,2016,17(2):188-198.
|
|
[35] LUO G,XIA X,WANG X,et al. miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer[J]. Exp Cell Res,2018,369(1):120-128.
|
DownLoad: